Jason N. Gorevic's most recent trade in Kemper Corporation was a trade of 4,730 Common Stock done at an average price of $32.8 . Disclosure was reported to the exchange on May 6, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kemper Corp | Jason N. Gorevic | Director | Grant, award, or other acquisition of securities at price $ 32.77 per share. | 06 May 2026 | 4,730 | 26,802 (0%) | 0% | 32.8 | 155,002 | Common Stock |
| Kemper Corp | Jason N. Gorevic | Director | Purchase of securities on an exchange or from another person at price $ 49.14 per share. | 07 Aug 2025 | 2,000 | 22,072 (0%) | 0% | 49.1 | 98,280 | Common Stock |
| Kemper Corp | Jason N. Gorevic | Director | Grant, award, or other acquisition of securities at price $ 61.61 per share. | 07 May 2025 | 2,435 | 20,072 (0%) | 0% | 61.6 | 150,020 | Common Stock |
| Kemper Corp | Jason N. Gorevic | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 2,565 | 17,637 (0%) | 0% | 0 | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2024 | 197,728 | 197,728 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 63,393 | 63,393 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 62,004 | 124,008 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 62,004 | 699,180 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 14.52 per share. | 01 Mar 2024 | 53,755 | 653,073 (0%) | 0% | 14.5 | 780,308 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 21,130 | 42,263 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 21,130 | 622,864 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 7,648 | 706,828 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 7,648 | 0 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 5,782 | 0 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 5,782 | 631,561 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 5,615 | 22,460 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 5,615 | 637,176 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 2,915 | 0 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 2,915 | 625,779 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason Gorevic N. | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2023 | 5,615 | 604,611 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Gorevic Jason N. | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2023 | 5,615 | 28,075 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | N. Jason Gorevic | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 18.90 per share. | 01 Dec 2023 | 2,877 | 601,734 (0%) | 0% | 18.9 | 54,381 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 5,614 | 601,860 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 5,614 | 33,690 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 22.89 per share. | 01 Sep 2023 | 2,864 | 598,996 (0%) | 0% | 22.9 | 65,568 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 30.03 per share. | 27 Jul 2023 | 10,000 | 596,246 (0%) | 0% | 30.0 | 300,303 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 5,614 | 39,304 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 5,614 | 609,048 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 24.38 per share. | 01 Jun 2023 | 2,802 | 606,246 (0%) | 0% | 24.4 | 68,316 | Common Stock |
| Kemper Corp | Jason N. Gorevic | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 2,933 | 15,072 (0%) | 0% | 0 | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 186,012 | 186,012 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 25.91 per share. | 03 Mar 2023 | 22,040 | 603,434 (0%) | 0% | 25.9 | 571,078 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 22,458 | 588,922 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 22,458 | 44,918 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 15,476 | 605,240 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 15,476 | 0 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 9,104 | 589,764 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 9,104 | 0 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 25.36 per share. | 01 Mar 2023 | 8,262 | 580,660 (0%) | 0% | 25.4 | 209,541 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 7,648 | 616,779 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 7,648 | 7,648 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 5,828 | 5,828 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 5,782 | 622,561 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 5,782 | 5,782 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 3,891 | 0 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 3,891 | 609,131 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 2,913 | 625,474 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 2,913 | 2,915 | - | - | Performance Stock Units | |
| Kemper Corp | Jason N. Gorevic | Director | Purchase of securities on an exchange or from another person at price $ 43.00 per share. | 03 Aug 2022 | 3,000 | 12,139 (0%) | 0% | 43 | 129,000 | Common Stock |
| Kemper Corp | Jason N. Gorevic | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2022 | 2,525 | 9,139 (0%) | 0% | 0 | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2022 | 21,812 | 0 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2022 | 21,812 | 516,464 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2022 | 16,778 | 0 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2022 | 16,778 | 494,652 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 17,346 | 17,346 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 15,478 | 15,476 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 15,478 | 460,551 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 9,103 | 9,104 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 9,103 | 445,073 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 7,784 | 7,784 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 7,648 | 472,092 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 7,648 | 15,296 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 5,782 | 477,874 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 5,782 | 11,564 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 3,893 | 464,444 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 3,893 | 3,891 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 67,376 | 67,376 | - | - | Restricted Stock Units | |
| Kemper Corp | Jason N. Gorevic | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2022 | 614 | 6,614 (0%) | 0% | 0 | Common Stock | |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 150.33 per share. | 02 Nov 2021 | 5,237 | 440,733 (0%) | 0% | 150.3 | 787,257 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 151.40 per share. | 02 Nov 2021 | 4,763 | 435,970 (0%) | 0% | 151.4 | 721,132 | Common Stock |
| Teladoc Health Inc | Jason N. Gorevic | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 150.12 per share. | 03 Aug 2021 | 10,000 | 445,970 (0%) | 0% | 150.1 | 1,501,169 | Common Stock |